DMFS

MIBC - NA - PDL1 positive muscular invasive bladder cancer (MIBC) MIBC - (neo)adjuvant (NA) MIBC - NA - PDL1 positive

versus placebo
nivolumab alone vs. placebo 1 0.61 [0.42; 0.89], 1 RCT, I2=0%
unassessable degree of certainty